The Eleventh Session of the Codex Committee on Residues of Veterinary Drugs in Foods reached the following conclusions:
|
MATTERS FOR CONSIDERATION BY THE EXECUTIVE COMMITTEE AND/OR CODEX ALIMENTARIUS COMMISSION: - Advanced draft maximum residue limits for Alpha-Cypermethrin/Cypermethrin, Azaperone, Bovine Somatotropins, Diclazuril, Dihydrostreptomycin/Streptomycin, Febantel/Fenbendazole/Oxfendazole, Neomycin, Spectinomycin, Tilmicosin and Ceftiofur to the Commission for adoption at Step 8 (paras. 63, 64, 70, 75, 76, 77, 79, 80, 82, 94 and Appendix II); - Advanced proposed draft maximum residue limits for Febantel/Febendazole/Oxfendazole, Fluazuron, Nicarbazin, Benzylpenicillin/Procaine Benzylpenicillin, Spectinomycin and Moxidectin to the Commission for adoption at Step 5/8 (paras. 85, 86, 89, 90, 92, 96 and Appendix III); - Advanced proposed draft maximum residue limits for Chlortetracycline/Oxytetracycline/Tetracycline, Cyfluthrin, Danofloxacin, Eprinomectin, Flumequine, Imidocarb and Sarafloxacin to the Commission for adoption at Step 5 (paras. 83, 84, 87, 88, 91 and Appendix V); - Agreed to refer its discussions and suggestions concerning the Draft Code of Practice on Good Animal Feeding to the Executive Committee for consideration (para. 49); and - Agreed on the Priority List of Veterinary Drugs Requiring Evaluation or Reevaluation (para. 127 and Appendix VIII). - Decided to replace the current Codex maximum residue limits for Benzylpenicillin with combined maximum residue limits for Benzylpenicillin/Procaine penicillin (para. 90); OTHER MATTERS OF INTEREST TO THE COMMISSION - Agreed to consider and publish maximum residue limits for veterinary drugs in a new format to facilitate their readability and use as a reference source (para. 4); - Noted that the maximum residue limits for Oxytetracycline in fat tissue had been withdrawn and therefore deleted from the database of maximum residue limits for veterinary drugs (para. 7); - Requested JECFA and JMPR to convene an informal meeting to consider the need for harmonization and consistency between the bodies in the establishment of MRLs (paras. 8-11); - Noted WHO's request for better international cooperation in the field of non-human use of antimicrobials (para. 22); - Agreed to further consider the use of antimicrobials in animal production at its next meeting, taking into account the activities of other international bodies (para. 31); - Noted that the Codex Committee on Fish and Fishery Products was already taking action on several issues raised in the report of the Joint FAO/NACA/WHO Study Group on Food Safety Issues Associated with Products from Aquaculture (para. 34); - Agreed to append the discussion paper on Risk Analysis in the Codex Committee on Residues of Veterinary Drugs in Foods to its report for circulation and comment (para. 44); - Decided to retain draft maximum residue limits for Abamectin, Chlorotetracycline/Oxytetracycline/Tetracycline, Dexamethasone, Gentamicin, Thiamphenicol and Carazolol at Step 7 (paras. 61, 73, 74, 78, 81 and 93); - Decided to retain proposed draft maximum residue limits for Clenbuterol at Step 4 (para. 95); - Agreed to prepare a revised version of the discussion paper on the Review of Performance Based Criteria for Methods of Analysis and Sampling for Veterinary Drug Residues in Foods for consideration at its next meeting (para. 101); - Endorsed the modified approach for the consideration of the Identification of Routine Methods of Analysis and Sampling for Veterinary Drug Residues in Foods (para. 107); - Agreed to reinstate the ad hoc Working Group on Methods of Analysis and Sampling at its next Session (para. 110); - Requested the preparation of Guidelines on Residues at Injection Sites for circulation, comment and consideration at its next meeting (para. 115); - Requested the redrafting of the document on the Control of Residues in Milk and Milk Products in a format to allow it to be included as an Appendix to CAC/GL 16-1993 for circulation, comment and consideration at its next meeting (para. 119); - Agreed to convene the ad hoc Working Group on Priorities at its next session (para. 128); and - Requested the preparation of a discussion paper on Data
Requirements for the Establishment of Maximum Residue Limits for Veterinary
Drugs for Minor Species for consideration at its next meeting (para.
130). |
